Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-25

Clinical Trial Update: Neuroprotection With Dexmedetomidine in Patients Undergoing Elective Cardiac or Abdominal Surgery (Neuprodex) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating dexmedetomidine for neuroprotection to reduce delirium and postoperative cognitive deficit in patients undergoing elective car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Claudia Spies | Conditions: Delirium, Postoperative Cognitive Deficit (POCD) | Phase 4 | Status: COMPLETED